Diklofenak’ın bozunması, dönüşüm ürünleri ve çevresel akıbeti üzerine inceleme

Öz

Diklofenak, insan ve veterinerlik amaçlı yaygın kullanılan ilaçlardan biri olmuştur. Diklofenak’ın çevre ve organizmalar üzerindeki olumsuz etkilerinin ortaya çıkmasıyla, araştırma çalışmaları atıksudan uzaklaştırılmasına yönelmiştir. Atıksu ya da yüzeysel suda mikrogram düzeyindeki derişimlerine rağmen, endokrin sistemini bozabilir, bu da üst düzey organizmaların metabolizmasında dolayısıyla ekosistemde sorunlara yol açabilir. Bu nedenle diklofenakın tüketiminden başlayarak etkin diklofenak arıtımına, deşarj standartlarının belirlenmesine ve su yaşamının üst düzeyde korunmasına kadar uzanan bir yelpazede diklofenak kontrolü için acil önlemler alınmalıdır. Diklofenak ile ilgili diğer bir problem ise, fotoliz ve biyolojik reaksiyonları ile oluşan bozunma ürünlerinin atıksu arıtma tesislerinin çıkışında bulunmasıdır. Bu dönüşüm ürünleri organizmalar için daha fazla tehdit oluşturmaktadır. Dolayısıyla, bu derleme makalesi diklofenakın çevre üzerindeki olumsuz etkilerini, birincil diklofenak kaynaklarını, hayvanlar üzerindeki endokrin bozucu etkilerini, insan vücudundaki metabolizmasını, arıtma yaklaşımlarını, biyolojik ve kimyasal bozunma metabolitlerinin türünü veya dönüşüm ürünlerini vurgulamayı amaçlamaktadır.

Anahtar Kelimeler

• Diklofenak
• Endokrin bozucu kimyasal
• Farmasötikler
• Dönüşüm ürünleri
• Arıtma
• Diclofenac
• Endocrine disrupting chemicals
• Pharmaceuticals
• Transformation products
• Treatment

A review on diclofenac degradation, transformation products and their fate in the environment

Abstract

Diclofenac has been one of the widely consumed pharmaceuticals for human and veterinary purposes. The research studies are devoted to investigating its removal from wastewater since its adverse effect on the environment and the organisms have been revealed. Despite its microgram level concentrations in the wastewater or water bodies, it could disrupt the endocrine system, which leads to problems in the metabolism of the higher-level organisms and, thereby, the ecosystem. Therefore, urgent measures should be taken to control diclofenac starting from its consumption and extending to the efficient diclofenac treatment, determination of discharge standards, or the high-level protection of aquatic life. Another problem with diclofenac is the degradation end-products that form through photolysis, or biological reactions remain in the wastewater treatment plants' effluent. These transformation products create further threats for the organisms. This review paper aims to emphasize the adverse effects of diclofenac on the environment, the primary diclofenac sources, its endocrine disrupting effects on the animals, metabolism in the human body, treatment approaches, type of biological and chemical degradation metabolites, or transformation products.

Keywords

• Diclofenac
• Endocrine disrupting chemicals
• Pharmaceuticals
• Transformation products
• Treatment

Kaynakça

1. [1] Acuña V, Ginebreda A, Mor JR, Petrovic M, Sabater S, Sumpter J, Barceló D. "Balancing the health benefits and environmental risks of pharmaceuticals: Diclofenac as an example". Environment International, 85(12), 327-333, 2015.
2. [2] de Voogt P, Janex-Habibi ML, Sacher F, Puijker L, Mons M. "Development of a common priority list of pharmaceuticals relevant for the water cycle". Water Science and Technology, 59(1), 39-46, 2009.
3. [3] Green RE, Newton IAN, Shultz S, Cunningham AA, Gilbert M, Pain DJ, Prakash V. "Diclofenac poisoning as a cause of vulture population declines across the Indian subcontinent". Journal of Applied Ecology, 41(5), 793-800, 2004.
4. [4] McRae NK, Glover CN, Burket SR, Brooks BW, Gaw S. "Acute exposure to an environmentally relevant concentration of diclofenac elicits oxidative stress in the culturally important galaxiid fish Galaxias maculatus". Environmental Toxicology and Chemistry, 37(1), 224-235, 2018.
5. [5] Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Iqbal Chaudhry MJ, Arshad M, Mahmood S, Ali A, Ahmed Khan A. "Diclofenac residues as the cause of vulture population decline in Pakistan". Nature, 427(1), 630-633, 2004.
6. [6] Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele RD. "Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout". Aquatic Toxicology, 68(2), 141-150, 2004.
7. [7] Gonzalez-Rey M, Bebianno MJ. "Effects of non-steroidal anti-inflammatory drug (NSAID) diclofenac exposure in mussel Mytilus galloprovincialis". Aquatic Toxicology, 148(3), 221-230, 2014.
8. [8] Hong HN, Kim HN, Park KS, Lee S-K, Gu MB. "Analysis of the effects diclofenac has on Japanese medaka (Oryzias latipes) using real-time PCR". Chemosphere, 67(11), 2115-2121, 2007.

9. [9] Madikizela LM, Chimuka L. "Occurrence of naproxen, ibuprofen, and diclofenac residues in wastewater and river water of KwaZulu-Natal Province in South Africa". Environmental Monitoring and Assessment, 189(7), 348-359, 2017.
10. [10] Tran NH, Reinhard M, Gin KY-H. "Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review". Water Research, 133(6), 182-207, 2018.
11. [11] Yang YY, Liu WR, Liu YS, Zhao JL, Zhang QQ, Zhang M, Zhang J-N, Jiang Y-X, Zhang L-J, Ying G-G. "Suitability of pharmaceuticals and personal care products (PPCPs) and artificial sweeteners (ASs) as wastewater indicators in the Pearl River Delta, South China". Science of the Total Environment, 590-591(14), 611-619, 2017.
12. [12] Agunbiade FO, Moodley B. "Occurrence and distribution pattern of acidic pharmaceuticals in surface water, wastewater, and sediment of the Msunduzi River, Kwazulu-Natal, South Africa". Environmental Toxicology and Chemistry, 35(1), 36-46, 2016.
13. [13] Ali AM, Rønning HT, Alarif W, Kallenborn R, Al-Lihaibi SS. "Occurrence of pharmaceuticals and personal care products in effluent-dominated Saudi Arabian coastal waters of the Red Sea". Chemosphere, 175(10), 505-513, 2017.
14. [14] de Barros ALC, Schmidt FF, de Aquino SF, Afonso R. "Determination of nine pharmaceutical active compounds in surface waters from Paraopeba River Basin in Brazil by LTPE-HPLC-ESI-MS/MS". Environmental Science Pollution Research, 25(20), 19962-19974, 2018.
15. [15] Jelic A, Gros M, Ginebreda A, Cespedes-Sánchez R, Ventura F, Petrovic M, Barcelo D. "Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment". Water Research, 45(3), 1165-1176, 2011.
16. [16] Larsson E, Al-Hamimi S, Jonsson JA. "Behaviour of nonsteroidal anti-inflammatory drugs and eight of their metabolites during wastewater treatment studied by hollow fibre liquid phase microextraction and liquid chromatography mass spectrometry". Science of the Total Environment, 485-486(13), 300-308, 2014.
17. [17] Bort R, Macé K, Boobis A, Gómez-Lechón Ma-J, Pfeifer A, Castell J. "Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways". Biochemical Pharmacology, 58(5), 787-796, 1999.
18. [18] Stülten D, Zühlke S, Lamshöft M, Spiteller M. "Occurrence of diclofenac and selected metabolites in sewage effluents". Science of the Total Environment, 405(1), 310-316, 2008.
19. [19] Iovino P, Chianese S, Canzano S, Prisciandaro M, Musmarra D. "Photodegradation of diclofenac in wastewaters". Desalination and Water Treatment, 61(3), 293-297, 2017.
20. [20] Roscher J, Vogel M, Karst U. "Identification of ultraviolet transformation products of diclofenac by means of liquid chromatography and mass spectrometry". Journal of Chromatography A, 1457(31), 59-65, 2016.
21. [21] Aguera A, Perez Estrada LA, Ferrer I, Thurman EM, Malato S, Fernandez-Alba AR. "Application of time-of-flight mass spectrometry to the analysis of phototransformation products of diclofenac in water under natural sunlight". Journal of Mass Spectrometry, 40(7), 908-915, 2005.
22. [22] Bartels P, von Tümpling W. "Solar radiation influence on the decomposition process of diclofenac in surface waters". Science of the Total Environment, 374(1), 143-155, 2007.
23. [23] Salgado R, Pereira VJ, Carvalho G, Soeiro R, Gaffney V, Almeida C, Vale Cardoso V, Ferreira E, Benoliel MJ, Ternes TA, Oehmen A, Reis MA, Noronha JP. "Photodegradation kinetics and transformation products of ketoprofen, diclofenac and atenolol in pure water and treated wastewater". Journal of Hazardous Materials, 244-245(1), 516-527, 2013.
24. [24] Suarez S, Lema JM, Omil F. "Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions". Water Research, 44(10), 3214-3224, 2010.
25. [25] Moreira IS, Bessa VS, Murgolo S, Piccirillo C, Mascolo G, Castro PML. "Biodegradation of Diclofenac by the bacterial strain Labrys portucalensis F11". Ecotoxicology and Environment Safety, 152(6), 104-113, 2018.
26. [26] Palyzova A, Zahradnik J, Maresova H, Sokolova L, Kyslikova E, Grulich M, Stepanek V, Rezanka T, Kyslik P. "Potential of the strain Raoultella sp. KDF8 for removal of analgesics". Folia Microbiologica, 63(3), 273-282, 2018.
27. [27] Hata T, Kawai S, Okamura H, Nishida T. "Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation". Biodegradation, 21(5), 681-689, 2010.
28. [28] Marco-Urrea E, Perez-Trujillo M, Cruz-Morato C, Caminal G, Vicent T. "Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR". Journal of Hazardous Materials, 176(1-3), 836-842, 2010.
29. [29] Jewell KS, Falas P, Wick A, Joss A, Ternes TA. "Transformation of diclofenac in hybrid biofilm-activated sludge processes". Water Research, 105(18), 559-567, 2016.
30. [30] Zou H, Radke M, Kierkegaard A, MacLeod M, McLachlan MS. "Using chemical benchmarking to determine the persistence of chemicals in a swedish lake". Environmental Science & Technology, 49(3), 1646-1653, 2015.
31. [31] Buser H-R, Poiger T, Müller MD. "Occurrence and fate of the pharmaceutical drug diclofenac in surface waters:  rapid photodegradation in a lake". Environmental Science & Technology, 32(22), 3449-3456, 1998.
32. [32] Lonappan L, Brar SK, Das RK, Verma M, Surampalli RY. "Diclofenac and its transformation products: Environmental occurrence and toxicity-A review". Environment International, 96(9), 127-138, 2016.
33. [33] Zhang Y, Geissen SU, Gal C. "Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies". Chemosphere, 73(8), 1151-1161, 2008.
34. [34] Vieno N, Sillanpää M. "Fate of diclofenac in municipal wastewater treatment plant-a review". Environment International, 69(8), 28-39, 2014.
35. [35] Carballa M, Fink G, Omil F, Lema JM, Ternes T. "Determination of the solid–water distribution coefficient (Kd) for pharmaceuticals, estrogens and musk fragrances in digested sludge". Water Research, 42(1), 287-295, 2008.
36. [36] Altman R, Bosch B, Brune K, Patrignani P, Young C. "Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology". Drugs, 75(8), 859-877, 2015.
37. [37] Meylan WM, Howard PH. "Computer estimation of the Atmospheric gas-phase reaction rate of organic compounds with hydroxyl radicals and ozone". Chemosphere, 26(12), 2293-2299, 1993.
38. [38] Tixier C, Singer HP, Oellers S, Muller SR. "Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters". Environmental Science and Technology, 37(6), 1061-1068, 2003.
39. [39] Zou H, Radke M, Kierkegaard A, McLachlan MS. "Temporal Variation of Chemical Persistence in a Swedish Lake Assessed by Benchmarking". Environmental Science & Technology, 49(16), 9881-9888, 2015.
40. [40] Al-Rajab AJ, Sabourin L, Lapen DR, Topp E. "The nonsteroidal anti-inflammatory drug diclofenac is readily biodegradable in agricultural soils". Science of the Total Environment, 409(1), 78-82, 2010.
41. [41] Poiger T, Buser H-R, Müller MD. "Photodegradation of the pharmaceutical drug diclofenac in a lake: Pathway, field measurements, and mathematical modeling". Environmental Toxicology and Chemistry, 20(2), 256-263, 2001.
42. [42] Xu J, Wu L, Chang AC. "Degradation and adsorption of selected pharmaceuticals and personal care products (PPCPs) in agricultural soils". Chemosphere, 77(10), 1299-1305, 2009.
43. [43] Radke M, Ulrich H, Wurm C, Kunkel U. "Dynamics and Attenuation of Acidic Pharmaceuticals along a River Stretch". Environmental Science & Technology, 44(8), 2968-2974, 2010.
44. [44] Huschek G, Hansen PD, Maurer HH, Krengel D, Kayser A. "Environmental risk assessment of medicinal products for human use according to European Commission recommendations". Environmental Toxicology, 19(3), 226-240, 2004.
45. [45] Ferrari Bt, Paxéus N, Giudice RL, Pollio A, Garric J. "Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac". Ecotoxicology and Environmental Safety, 55(3), 359-370, 2003.
46. [46] Jones OAH, Voulvoulis N, Lester JN. "Aquatic environmental assessment of the top 25 English prescription pharmaceuticals". Water Research, 36(20), 5013-5022, 2002.
47. [47] Bound Jonathan P, Voulvoulis N. "Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom". Environmental Health Perspectives, 113(12), 1705-1711, 2005.
48. [48] Patel M, Kumar R, Kishor K, Mlsna T, Pittman CU, Mohan D. "Pharmaceuticals of emerging concern in aquatic systems: chemistry, occurrence, effects, and removal methods". Chemical Reviews, 119(6), 3510-3673, 2019.
49. [49] Rastetter N, Gerhardt A. "Toxic potential of different types of sewage sludge as fertiliser in agriculture: ecotoxicological effects on aquatic, sediment and soil indicator species". Journal of Soils and Sediments, 17(1), 106-121, 2017.
50. [50] Heberer T, Feldmann D. "Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents--modeling versus measurements". Journal of Hazardous Materials, 122(3), 211-218, 2005.
51. [51] Yang Y, Fu J, Peng H, Hou L, Liu M, Zhou JL. "Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone". Journal of Hazardous Materials, 190(1), 588-596, 2011.
52. [52] Lee H-B, Peart TE, Svoboda ML. "Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid-phase extraction and gas chromatography–mass spectrometry". Journal of Chromatography A, 1094(1), 122-129, 2005.
53. [53] Rivera-Jaimes JA, Postigo C, Melgoza-Aleman RM, Acena J, Barcelo D, Lopez de Alda M. "Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: Occurrence and environmental risk assessment". Science of the Total Environment, 613-614(3), 1263-1274, 2018.
54. [54] Yang Y, Ok YS, Kim K-H, Kwon EE, Tsang YF. "Occurrences and removal of pharmaceuticals and personal care products (PPCPs) in drinking water and water/sewage treatment plants: A review". Science of the Total Environment, 596-597(18), 303-320, 2017.
55. [55] Sun Q, Li M, Ma C, Chen X, Xie X, Yu CP. "Seasonal and spatial variations of PPCP occurrence, removal and mass loading in three wastewater treatment plants located in different urbanization areas in Xiamen, China". Environmental Pollution, 208(1), 371-381, 2016.
56. [56] Behera SK, Kim HW, Oh JE, Park HS. "Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea". Science of the Total Environment, 409(20), 4351-4360, 2011.
57. [57] Anumol T, Vijayanandan A, Park M, Philip L, Snyder SA. "Occurrence and fate of emerging trace organic chemicals in wastewater plants in Chennai, India". Environment International, 92-93(6), 33-42, 2016.
58. [58] Tran NH, Gin KY. "Occurrence and removal of pharmaceuticals, hormones, personal care products, and endocrine disrupters in a full-scale water reclamation plant". Science of the Total Environment, 599-600(20), 1503-1516, 2017.
59. [59] Osorio V, Imbert-Bouchard M, Zonja B, Abad JL, Perez S, Barcelo D. "Simultaneous determination of diclofenac, its human metabolites and microbial nitration/nitrosation transformation products in wastewaters by liquid chromatography/quadrupole-linear ion trap mass spectrometry". Journal of Chromatography A, 1347(25), 63-71, 2014.
60. [60] Kosma CI, Lambropoulou DA, Albanis TA. "Investigation of PPCPs in wastewater treatment plants in Greece: Occurrence, removal and environmental risk assessment". Science of the Total Environment, 466-467(1), 421-438, 2014.
61. [61] Sari S, Ozdemir G, Yangin-Gomec C, Zengin GE, Topuz E, Aydin E, Pehlivanoglu-Mantas E, Okutman Tas D. "Seasonal variation of diclofenac concentration and its relation with wastewater characteristics at two municipal wastewater treatment plants in Turkey". Journal of Hazardous Materials, 272, 155-164, 2014.
62. [62] Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. "The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters". Water Research, 43(2), 363-380, 2009.
63. [63] Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N, Kroiss H. "Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants". Water Research, 39(19), 4797-4807, 2005.
64. [64] Kołecka K, Gajewska M, Stepnowski P, Caban M. "Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology". Science of the Total Environment, 647(2), 149-157, 2019.
65. [65] Lindholm-Lehto PC, Ahkola HS, Knuutinen JS, Herve SH. "Widespread occurrence and seasonal variation of pharmaceuticals in surface waters and municipal wastewater treatment plants in central Finland". Environmental Science Pollution Research, 23(8), 7985-7997, 2016.
66. [66] Lindqvist N, Tuhkanen T, Kronberg L. "Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters". Water Research, 39(11), 2219-2228, 2005.
67. [67] Vulliet E, Cren-Olivé C, Grenier-Loustalot M-F. "Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters". Environmental Chemistry Letters, 9(1), 103-114, 2011.
68. [68] Veras TB, Luiz Ribeiro de Paiva A, Duarte MMMB, Napoleão DC, da Silva Pereira Cabral JJ. "Analysis of the presence of anti-inflammatories drugs in surface water: A case study in Beberibe river- PE, Brazil". Chemosphere, 222(9), 961-969, 2019.
69. [69] Nödler K, Voutsa D, Licha T. "Polar organic micropollutants in the coastal environment of different marine systems". Marine Pollution Bulletin, 85(1), 50-59, 2014.
70. [70] Korkmaz NE, Savun-Hekimoğlu B, Aksu A, Burak S, Caglar NB. "Occurrence, sources and environmental risk assessment of pharmaceuticals in the Sea of Marmara, Turkey". Science of the Total Environment, 819(18), 1-13, 2022.
71. [71] Borecka M, Siedlewicz G, Haliński ŁP, Sikora K, Pazdro K, Stepnowski P, Białk-Bielińska A. "Contamination of the southern Baltic Sea waters by the residues of selected pharmaceuticals: Method development and field studies". Marine Pollution Bulletin, 94(1), 62-71, 2015.
72. [72] Scheurell M, Franke S, Shah RM, Huhnerfuss H. "Occurrence of diclofenac and its metabolites in surface water and effluent samples from Karachi, Pakistan". Chemosphere, 77(6), 870-876, 2009.
73. [73] Praveena SM, Shaifuddin SNM, Sukiman S, Nasir FAM, Hanafi Z, Kamarudin N, Ismail THT, Aris AZ. "Pharmaceuticals residues in selected tropical surface water bodies from Selangor (Malaysia): Occurrence and potential risk assessments". Science of the Total Environment, 642(24), 230-240, 2018.
74. [74] González-Alonso S, Merino LM, Esteban S, López de Alda M, Barceló D, Durán JJ, López-Martínez J, Aceña J, Pérez S, Mastroianni N, Silva A, Catalá M, Valcárcel Y. "Occurrence of pharmaceutical, recreational and psychotropic drug residues in surface water on the northern Antarctic Peninsula region". Environmental Pollution, 229(11), 241-254, 2017.
75. [75] Abu-Seida AM. "Efficacy of diclofenac sodium, either alone or together with cefotaxime sodium, for control of postoperative pain, in dogs undergoing ovariohysterectomy". Asian Journal of Animal and Veterinary Advances, 7(2), 180-186, 2012.
76. [76] Camiña A, Aguilera J, Sarrazin F, Duriez O. "Potential exposure to diclofenac in Spain of European vultures". Vulture News, 75(2), 1-20, 2018.
77. [77] Borghi SM, Fattori V, Ruiz-Miyazawa KW, Bertozzi MM, Lourenco-Gonzalez Y, Tatakihara RI, Bussmann AJC, Mazzuco TL, Casagrande R, Verri WA, Jr. "Pyrrolidine dithiocarbamate inhibits mouse acute kidney injury induced by diclofenac by targeting oxidative damage, cytokines and NF-kappaB activity". Life Sciences, 208(17), 221-231, 2018.
78. [78] Eades C, Waring CP. "The effects of diclofenac on the physiology of the green shore crab Carcinus maenas". Marine Environment Research, 69 (Supplement 1), 46-48, 2010.
79. [79] Bamber SD, Depledge MH. "Responses of shore crabs to physiological challenges following exposure to selected environmental contaminants". Aquatic Toxicology, 40(1), 79-92, 1997.
80. [80] Sonnenschein C, Soto A. "An updated review of environmental estrogen and androgen mimics and antagonists". The Journal of Steroid Biochemistry and Molecular Biology, 65(1-6), 143-150, 1998.
81. [81] Gröner F, Höhne C, Kleiner W, Kloas W. "Chronic diclofenac exposure affects gill integrity and pituitary gene expression and displays estrogenic activity in nile tilapia (Oreochromis niloticus)". Chemosphere, 166(1), 473-481, 2017.
82. [82] Klopčič I, Markovič T, Mlinarič-Raščan I, Sollner Dolenc M. "Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4- hydroxydiclofenac and paracetamol". Toxicology Letters, 294(13), 95-104, 2018.
83. [83] European Commission. "Commission Implementing Decision (EU) 2015/495 of 20 March 2015 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council (notified under document C(2015) 1756) Text with EEA relevance". http://data.europa.eu/eli/dec_impl/2015/495/oj (08.03.2022).
84. [84] Stierlin H, Faigle JW, Sallmann A, Kung W, Richter WJ, Kriemler HP, Alt KO, Winkler T. "Biotransformation of diclofenac sodium (Voltaren®) in animals and in man". Xenobiotica, 9(10), 601-610, 1979.
85. [85] Stülten D, Lamshoft M, Zuhlke S, Spiteller M. "Isolation and characterization of a new human urinary metabolite of diclofenac applying LC-NMR-MS and high-resolution mass analyses". Journal of Pharmaceutical and Biomedical Analysis, 47(2), 371-376, 2008.
86. [86] Stierlin H, Faigle JW. "Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile". Xenobiotica, 9(10), 611-621, 1979.
87. [87] Zhang Y, Han YH, Putluru SP, Matta MK, Kole P, Mandlekar S, Furlong MT, Liu T, Iyer RA, Marathe P, Yang Z, Lai Y, Rodrigues AD. "Diclofenac and Its Acyl Glucuronide: Determination of In Vivo Exposure in Human Subjects and Characterization as Human Drug Transporter Substrates In Vitro". Drug Metabolism and Disposition, 44(3), 320-328, 2016.
88. [88] Wiesenberg-Boettcher I, Pfeilschifter J, Schweizer A, Sallmann A, Wenk P. "Pharmacological properties of five diclofenac metabolites identified in human plasma". Agents Actions, 34(1-2), 135-137, 1991.
89. [89] Wilkinson J, Hooda PS, Barker J, Barton S, Swinden J. "Occurrence, fate and transformation of emerging contaminants in water: An overarching review of the field". Environmental Pollution, 231(1), 954-970, 2017.
90. [90] Zhang N, Liu G, Liu H, Wang Y, He Z, Wang G. "Diclofenac photodegradation under simulated sunlight: Effect of different forms of nitrogen and Kinetics". Journal of Hazardous Materials, 192(1), 411-418, 2011.
91. [91] Sokół A, Borowska K, Karpińska J. "Investigating the ınfluence of some environmental factors on the stability of paracetamol, naproxen, and diclofenac in simulated natural conditions". Polish Journal of Environmental Studies, 26(1), 293-302, 2017.
92. [92] Zhang N, Li JM, Liu GG, Chen XL, Jiang K. "Photodegradation of diclofenac in aqueous solution by simulated sunlight irradiation: kinetics, thermodynamics and pathways". Water Science and Technology, 75(9), 2163-2170, 2017.
93. [93] Moore DE, Roberts-Thomson S, Zhen D, Duke CC. "Photochemical studies on the antiinflammatory drug diclofenac". Photochemistry and Photobiology, 52(4), 685-690, 1990.
94. [94] Nguyen LN, Nghiem LD, Pramanik BK, Oh S. "Cometabolic biotransformation and impacts of the anti-inflammatory drug diclofenac on activated sludge microbial communities". Science of the Total Environment, 657(12), 739-745, 2019.
95. [95] Kosjek T, Heath E, Pérez S, Petrović M, Barceló D. "Metabolism studies of diclofenac and clofibric acid in activated sludge bioreactors using liquid chromatography with quadrupole-time-of-flight mass spectrometry". Journal of Hydrology, 372(1), 109-117, 2009.
96. [96] Poirier-Larabie S, Segura PA, Gagnon C. "Degradation of the pharmaceuticals diclofenac and sulfamethoxazole and their transformation products under controlled environmental conditions". Science of the Total Environment, 557-558(15), 257-267, 2016.
97. [97] Barbieri M, Carrera J, Ayora C, Sanchez-Vila X, Licha T, Nödler K, Osorio V, Pérez S, Köck-Schulmeyer M, López de Alda M, Barceló D. "Formation of diclofenac and sulfamethoxazole reversible transformation products in aquifer material under denitrifying conditions: Batch experiments". Science of the Total Environment, 426(11), 256-263, 2012.
98. [98] Lahti M, Oikari A. "Microbial transformation of pharmaceuticals naproxen, bisoprolol, and diclofenac in aerobic and anaerobic environments". Archives of Environment Contamination and Toxicology, 61(2), 202-210, 2011.
99. [99] Jayasinghe C, Imtiaj A, Lee GW, Im KH, Hur H, Lee MW, Yang HS, Lee TS. "Degradation of three aromatic dyes by white rot fungi and the production of ligninolytic enzymes". Mycobiology, 36(2), 114-120, 2008.
100. [100]McMullan G, Meehan C, Conneely A, Kirby N, Robinson T, Nigam P, Banat I, Marchant R, Smyth W. "Microbial decolourisation and degradation of textile dyes". Applied Microbiology and Biotechnology, 56(1), 81-87, 2001.
101. [101] Swamy J, Ramsay JA. "The evaluation of white rot fungi in the decoloration of textile dyes". Enzyme and Microbial Technology, 24(3), 130-137, 1999.
102. [102] Bhatt M, Cajthaml T, Šašek V. "Mycoremediation of PAHcontaminated soil". Folia Microbiologica, 47(3), 255-258, 2002.
103. [103] Field JA, de Jong E, Feijoo Costa G, de Bont JA. "Biodegradation of polycyclic aromatic hydrocarbons by new isolates of white rot fungi". Applied and Environmental Microbiology, 58(7), 2219-2226, 1992.
104. [104] Zhang H, Zhang S, He F, Qin X, Zhang X, Yang Y. "Characterization of a manganese peroxidase from whiterot fungus Trametes sp.48424 with strong ability of degrading different types of dyes and polycyclic aromatic hydrocarbons". Journal of Hazardous Materials, 320(20), 265-277, 2016.
105. [105] Shreve MJ, Brockman A, Hartleb M, Prebihalo S, Dorman FL, Brennan RA. "The white-rot fungus Trametes versicolor reduces the estrogenic activity of a mixture of emerging contaminants in wastewater treatment plant effluent". International Biodeterioration & Biodegradation, 109(4), 132-140, 2016.
106. [106] Yang S, Hai FI, Nghiem LD, Nguyen LN, Roddick F, Price WE. "Removal of bisphenol A and diclofenac by a novel fungal membrane bioreactor operated under non-sterile conditions". International Biodeterioration & Biodegradation, 85(10), 483-490, 2013.
107. [107] Asif MB, Hai FI, Singh L, Price WE, Nghiem LD. "Degradation of Pharmaceuticals and Personal Care Products by White-Rot Fungi-a Critical Review". Current Pollution Reports, 3(2), 88-103, 2017.
108. [108] Marco-Urrea E, Pérez-Trujillo M, Cruz-Morató C, Caminal G, Vicent T. "White-rot fungus-mediated degradation of the analgesic ketoprofen and identification of intermediates by HPLC-DAD–MS and NMR". Chemosphere, 78(4), 474-481, 2010.
109. [109] Marco-Urrea E, Pérez-Trujillo M, Vicent T, Caminal G. "Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor". Chemosphere, 74(6), 765-772, 2009.
110. [110] Rodarte-Morales AI, Feijoo G, Moreira MT, Lema JM. "Degradation of selected pharmaceutical and personal care products (PPCPs) by white-rot fungi". World Journal of Microbiology and Biotechnology, 27(8), 1839-1846, 2011.
111. [111] Schmidt S, Hoffmann H, Garbe LA, Schneider RJ. "Liquid chromatography-tandem mass spectrometry detection of diclofenac and related compounds in water samples". Journal of Chromatography A, 1538(8), 112-116, 2018.
112. [112] Suarez S, Reif R, Lema JM, Omil F. "Mass balance of pharmaceutical and personal care products in a pilotscale single-sludge system: influence of T, SRT and recirculation ratio". Chemosphere, 89(2), 164-171, 2012.
113. [113] Bouju H, Nastold P, Beck B, Hollender J, Corvini PFX, Wintgens T. "Elucidation of biotransformation of diclofenac and 4′hydroxydiclofenac during biological wastewater treatment". Journal of Hazardous Materials, 301(1), 443-452, 2016.
114. [114] Zhou H, Liu J, Chen X, Ying Z, Zhang Z, Wang M. "Fate of pharmaceutically active compounds in sewage sludge during anaerobic digestions integrated with enzymes and physicochemical treatments". Waste Management, 78, 911-916, 2018.
115. [115] Kummerová M, Zezulka Š, Babula P, Tříska J. "Possible ecological risk of two pharmaceuticals diclofenac and paracetamol demonstrated on a model plant Lemna minor". Journal of Hazardous Materials, 302(2), 351-361, 2016.